CH
Cochlear Limited
CHEOY · OTC
$48.12 -1.57% (-$0.77)
1M +2.82%
Market Cap $8.94B
P/E Ratio 60.68x
Div. Yield 2.97%
ROE 7.86%
Bulios Fair Price
$33.52
30.3% downside
Current Price
$48.12
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CHEOY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
20 /100
Expensive EV/EBITDA 27.02x
P/S 3.81x
P/B 5.14x
Growth
40 /100
Stable FCF growth 1.33%
Book val. growth 0.16%
Rev. growth 6.28%
Profitability
62 /100
Moderate Net margin 6.27%
Op. margin 8.91%
FCF margin 11.81%
Quality
45 /100
Average ROE 7.86%
ROA 5.66%
Asset turnover 0.90x
Debt
100 /100
Low Current ratio 2.15x
Int. coverage 17.20x
Net debt/EBITDA 0.08x
Stability
54 /100
Moderate Rev. volatility 7.20%
EPS volatility 66.15%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CHEOY
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Diggory William Howitt
Employees
5,400
Headquarters
Sydney
Upcoming events
22 SEP
Ex-Dividend
Ex-dividend date
03 NOV
Dividend Payment
Payment date